SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Sepracor-Looks very promising

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Don Miller who wrote (3781)10/20/1999 1:59:00 PM
From: Don Miller  Read Replies (1) of 10280
 
CFO on CNBC Powerlunch today explained that fall off was really due to a large stock increase this quarter last year. He said after factoring out last years stocking they see sales flat to 3% down this quarter and next.

He failed to introduce Prozac-Plus when questioned about LLY strong dependance on Prozac, instead he said they have six diversifying drugs coming forward. Said Prozac generic threat does not come until mid-2004.

Don
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext